United States Milk Powder Forecasts Report 2024: Market to Reach $13.73 Billion by 2030, Driven by Societal Shift Towards Convenience-driven Consumption Patterns
DUBLIN, March 21, 2024 /PRNewswire/ — The “United States Milk Powder Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. United States Milk Powder Mar
GLN International, Signs MOU with Fonepay to explore possible collaboration opportunities for cross-border QR payment between Korea and Nepal
SEOUL, South Korea, March 22, 2024 /PRNewswire/ — GLN International (Kyungho Kim, CEO), a global payment network provider company, announced that it signed an MOU with Fonepay Payment Service Ltd, Nepal’s largest payment network, to explore opportunities to integrate its system to provid
DNA Sequencing Market Projected to Reach $210.34 billion by 2030 – Exclusive Report by 360iResearch
PUNE, India, March 21, 2024 /PRNewswire/ — The report titled “DNA Sequencing Market by Product & Services (Consumables, Instruments, Services), Technology (Next-Generation Sequencing, Sanger Sequencing, Third Generation DNA Sequencing), Workflow, Application – Global Forecast 2
United States Personalized Gifting Insights Report 2024: Market to Grow by Over $4 Billion to 2029, Driven by Premium Gifting and Focus on Continuous Product Innovation
DUBLIN, March 21, 2024 /PRNewswire/ — The “U.S. Personalized Gifting Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The U.S. personalized gifting market was valued at $9.07 billion in 2023 and is expected to reach a
AGL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that agilon health, inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, March 21, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against agilon health, inc. (“agilon” or “the Company”) (NYSE: AG
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001
BOSTON and HANGZHOU and SHANGHAI, China, March 22, 2024 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), a clinical-stage innovative drug development company, announced that it has dosed the first patient with Atopic Dermatitis (A
Newborn Town Announces 2023 Annual Results with a YoY Increase of Nearly 300% in Profit Attributable to Owners and Rise in Second-mover Apps
HONG KONG, March 22, 2024 /PRNewswire/ — Newborn Town (“Newborn Town”; 9911. HK), one of the frontrunners of the global social networking and entertainment industry, announced its 2023 annual results on March 21st. The company’s revenue increased solidly in 2023, reaching RM
Canada Tractors Market Industry Report 2024 – Compound Annual Growth of 2.5% Forecast During 2023-2029, with Market Set to Reach 32,270 Units in 2029
DUBLIN, March 21, 2024 /PRNewswire/ — The “Canada Tractors Market – Industry Analysis & Forecast 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The Canadian tractors market witnessed shipments of 27,823 units in 2023 and is expected to grow
BANF Smart Tire collaborates with CampX by Volvo Group
Collaboration Redefining Intelligent Tire Technology Efficacy. SEOUL, South Korea, March 21, 2024 /PRNewswire/ — BANF, a leader in smart tire technology, collaborates with CampX by Volvo Group in a Proof of Value (PoV) project, co-creating on intelligent tire safety and fuel efficiency optimiz
NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy
SUZHOU, China, March 21, 2024 /PRNewswire/ — NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004. This milestone represents si